What are the recommended dosages of etomidate and succinylcholine (Succinylcholine) in milligrams per kilogram (mg/kg) for Rapid Sequence Intubation (RSI) in an adult or pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Intubation: Etomidate and Succinylcholine Dosing

Standard Dosing Recommendations

For RSI, administer etomidate 0.3 mg/kg IV followed immediately by succinylcholine 1-2 mg/kg IV (1.5 mg/kg for infants <6 months). 1, 2, 3

Etomidate Dosing

  • Standard dose: 0.3 mg/kg IV administered as a single bolus over 30-60 seconds 2, 3, 4
  • This dose provides optimal sedation while maintaining hemodynamic stability in critically ill patients 2, 3
  • Dose range: 0.2-0.3 mg/kg is acceptable, but 0.3 mg/kg is preferred for RSI 2, 4
  • In hemodynamically compromised patients, consider reducing to 0.15-0.2 mg/kg to minimize cardiovascular effects 2

Succinylcholine Dosing

  • Standard IV dose: 1-2 mg/kg (use 2 mg/kg for infants <6 months) 1
  • Intramuscular dose: 4 mg/kg (5 mg/kg for infants <6 months) if IV access unavailable 1
  • Dose based on actual body weight, not ideal body weight 2
  • Onset of action: 30-45 seconds IV, 3-5 minutes IM 1
  • Duration of action: 5-10 minutes 1

Critical Timing and Sequence

The sedative-hypnotic agent (etomidate) MUST be administered before the neuromuscular blocking agent (succinylcholine) to prevent awareness during paralysis. 2, 3

  • Administer etomidate first as a single IV bolus 3
  • Immediately follow with succinylcholine as early as practical after induction to minimize apnea time 2
  • Wait 30-45 seconds after succinylcholine administration before attempting intubation 1

Essential Premedication

Administer atropine 0.02 mg/kg (minimum 0.1 mg, maximum 1 mg) before succinylcholine to prevent bradycardia or asystole. 1

  • This is particularly important in pediatric patients 1
  • In patients with increased intracranial pressure, consider a defasciculation dose of vecuronium 0.01 mg/kg before succinylcholine 1

Critical Contraindications to Succinylcholine

Do NOT use succinylcholine in patients with: 1

  • Previous history of malignant hyperthermia
  • Severe burns or crush injury
  • Spinal cord injury
  • Neuromuscular disease or myopathy
  • Risk of hyperkalemia (particularly in boys <9 years old)

In these cases, use rocuronium 1.0-1.2 mg/kg IV instead 2, 3

Dosing Pitfalls to Avoid

Etomidate Under-Dosing

  • Patients weighing ≥100 kg are at high risk for under-dosing 5
  • 68% of patients ≥100 kg received inadequate doses (<0.2 mg/kg) in one study 5
  • Always calculate the dose based on actual body weight and verify the total mg dose 5

Etomidate Over-Dosing

  • Do NOT exceed 0.3 mg/kg as higher doses increase respiratory depression risk without improving intubating conditions 2, 4
  • Doses ≥0.23 mg/kg in patients >55 years were associated with oxygen desaturation requiring bag-assisted ventilation 1, 4

Succinylcholine Dosing Errors

  • Use actual body weight, not ideal body weight for dosing calculation 2
  • Ensure adequate dose (minimum 1 mg/kg) to achieve complete paralysis and prevent patient movement during intubation 1

Pediatric-Specific Considerations

  • Etomidate dose: 0.2-0.3 mg/kg IV (same as adults) 4
  • Succinylcholine dose: 2 mg/kg IV for infants <6 months, 1-2 mg/kg for older children 1
  • Always premedicate with atropine 0.02 mg/kg to prevent bradycardia 1
  • In septic shock, strongly consider ketamine (1-2 mg/kg) instead of etomidate due to adrenal suppression concerns 2

Safety Monitoring Requirements

Have immediately available: 1, 3

  • Vasopressors for hypotension management
  • Bag-valve-mask for ventilatory support
  • Suction equipment
  • Age-appropriate intubation equipment
  • Continuous pulse oximetry and cardiac monitoring

Adrenal Suppression Controversy

  • Etomidate causes transient adrenal suppression, but corticosteroid administration following etomidate is NOT recommended 2
  • No mortality difference has been demonstrated between etomidate and other induction agents in critically ill adults 2, 3
  • However, avoid etomidate in pediatric septic shock—use ketamine instead 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rapid Sequence Intubation for Critically Ill Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Etomidate Dosing for Pediatric Conscious Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What medications are typically given before emergency intubation in a typical adult patient without specific allergies or contraindications?
What is the process for rapid endotracheal intubation (ETI)?
What are the best medications for Repetitive Strain Injury (RSI)?
What is the recommended medication regimen for Rapid Sequence Intubation (RSI)?
What are the recommendations for intubating unresponsive patients without medication, such as sedatives (e.g. etomidate) and paralytics (e.g. rocuronium)?
Does diclofenac (nonsteroidal anti-inflammatory drug (NSAID)) impair tendon healing in adults?
What is the appropriate medication management for a patient with neurotic excoriation, considering their past medical history and potential for underlying psychiatric conditions or skin disorders?
What is the prevalence of sweating in patients with pre-existing cardiovascular conditions taking stimulant medications, such as Ritalin (methylphenidate) or Adderall (amphetamines), for Attention Deficit Hyperactivity Disorder (ADHD)?
What is the appropriate diagnostic workup and treatment approach for a patient presenting with Ronchi lung sounds, potentially associated with underlying respiratory conditions such as COPD or asthma?
What is the preferred initial treatment with Dapagliflozin (SGLT2 inhibitor) vs Farxiga (Dapagliflozin) for a patient with type 2 diabetes and a history of cardiovascular disease or kidney disease?
What are the treatment options for an adult patient with constipation and no significant medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.